Burden of the central nervous system malignancies in Iran 2003

AR. Zali; F. Abolhassani; Maryam Khayamzade; M. Moradi Lake; A. Jamali; R. Salmanian; M. Naghavi; HR. Mirzaei; A. Kazemian; ME. Akbari

International Journal of Cancer Management

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

Outlines

Abstract
Copyright

Burden of the central nervous system malignancies in Iran 2003

Author(s):

AR. Zali¹,

F. Abolhassani²,

Maryam Khayamzade^3,*,

M. Moradi Lake⁴,

A. Jamali⁴,

R. Salmanian⁵,

M. Naghavi⁶,

HR. Mirzaei⁷,

A. Kazemian⁸,

ME. Akbari⁹

1Associated Profurgery Shahid Beheshti Medical Universityessor of Neuros, Tehran, Iran

2Assistant Professor of Endocrine and metabolism Research Center, Tehran Medical University, Tehran, Iran

3Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4Community Medicine Specialist Assistant Professor of Iran Medical University, Tehran, Iran

5Resident of Anestisiology Iran Medical University, Tehran, Iran

6Epidemiologist (MD-PhD) Researcher- Ministry Of health and Medical Education, Iran

7Radio therapy oncology specialist - Cancer Research Center, Assistant Professor of Shahid Beheshti Medical University, Tehran, Iran

8Radio therapy oncology specialist, Assistant Professor of Tehran Medical University, Tehran, Iran

9Professor of Surgery- Cancer Research Center, Shahid Beheshti Medical University, Tehran, Iran

International Journal of Cancer Management:Vol. 1, issue 1; e80377

Published online:Jan 31, 2008

Article type:Research Article

Received:Jan 31, 2008

Accepted:Jan 31, 2008

How to Cite:AR. ZaliF. AbolhassaniMaryam KhayamzadeM. Moradi LakeA. JamaliR. SalmanianM. NaghaviHR. MirzaeiA. KazemianME. Akbariet al.Burden of the central nervous system malignancies in Iran 2003.Int J Cancer Manag.1(1):e80377.

Abstract

Objective: The policy makers and social managers need some criteria for building up the appropriate health status of the community and observe the equity and equality on it. They have to know the burden of diseases as a main determining factor for decision making, planning and programming. Disability adjusted life years (DALYs) is a criteria which shows the wasted life time due to early death and also wasted time due to disease morbidity and disability. Central nervous system malignancies are important especially in children and estimating the burden of these malignancies in Iran will enable the health policy makers to share the community sources, as appropriate.

Material and Methods: The estimation of burden of disease and risk factors was a national study that began on 2003 by the ministry of Health and Medical education (MOH&ME) after establishing cancer registry in the country. Here by we discussed about the burden of CNS malignancies as a part of this study. This study was performed by a special modeling and new software.

Results: Due to wasted life time of early death and morbidity, CNS malignancies are the third malignancy in Iran. Year waste in Iranian Population is 0.69 in each 1000 person.

Keywords

Fulltext

Full text is available in PDF.

comments